TheralinkTheralink

  • Theralink
    • The Theralink platform
    • The Theralink Assay
    • Request RPPA Analyte List
    • RPPA Clinical Publications
    • RPPA Research Publications
    • RPPA Technical Publications
  • About
    • Overview
    • Oncologists
    • Mission Statement
    • Management Team
    • Medical Advisory Board
    • Scientific Advisory Board
    • Board of Directors
    • Career
  • News & Media
    • Press Releases
    • Media Coverage
  • Biopharmas
    • Overview
    • Explore Technology
    • Explore Targets
    • Explore Pathways
    • Build-a-Pathway
    • FAQ
  • INVESTOR RELATIONS
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial Information
    • Stock Information
    • Investor Resources
      • FAQ
      • Contact Us
    • Corporate Governance
      • Management Team
      • Medical Advisory Board
      • Scientific Advisory Board
      • Board of Directors
  • Contact

Press releases

Theralink   →  Media Room   →  Press releases
Posted on June 17, 2020June 17, 2020

OncBioMune d/b/a Theralink® Technologies Launches New Corporate Website

  Golden, Colorado – June 17, 2020 – OncBioMune (OTC: OBMP) d/b/a Theralink Technologies, a molecular profiling compan...
Read More
Posted on June 10, 2020June 11, 2020

OncBioMune Appoints Dr. Mick Ruxin as President & CEO and Jeffrey Busch as Chairman of the Board

  Golden, Colorado - June 10, 2020 - OncBioMune Pharmaceuticals, Inc. (OTC: OBMP) (“OncBioMune”) today announced the a...
Read More
Posted on June 8, 2020June 11, 2020

OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics

  Avant Diagnostics provides personalized medicine data for physicians and measures the activation state of key drug targets...
Read More
Previous page 1 2

Categories

  • Events
  • Investor Presentation
Theralink Technologies intends to be a market leader in precision medicine for more effective cancer treatments

Menu

  • About
  • Investors
  • Contact
  • Privacy Policy

OUR SERVICES

  • Biopharmas
  • Oncologists
  • Media Room

Press Releases

  • Theralink® Technologies Issues Letter to Shareholders
  • Theralink® Technologies Announces Partnership with Perthera to Facilitate and Accelerate Access to its Unique Phosphoprotein and Drug Target Activation Testing in the U.S.
  • Theralink® Technologies Appoints Thomas Chilcott as Chief Financial Officer
Copyright © 2020 Theralink. All rights reserved.
We use cookies to improve your experience on our site. If you continue the use of this site then you accept our terms of use and privacy policy.Terms & Privacy